Fig. 1: Male type of genitalia with early appearance of secondary sexual characteristics

Fig. 2: Masculin features of the patient
was present, increased body hair, axillary hair began to appear and pubic hair distribution was adult male pattern. Pulse was 100 beats/min, Blood pressure was-100/60 mm of Hg. Her weight was 20 kg, height was 104cm. Weight for age Z-score (WAZ) was +3.7, Weight for height Z-score was (WHZ)=+1.58, Height for age Z-score (HAZ) was +2. On systemic examination-Clitoris was enlarged resembling penis which was about 3.5 cm in length, pubic hair coarse, curly, vaginal orifice intact and urethral orifice normal in position. There was no breast bud, SMR was B1-A2-P3. Examinations of other systems revealed nothing abnormal.
The baby was investigated for complete blood count. Hemoglobin (Hb) was 13 gm/dl, ESR was 10 mm in the first hour. Total count of WBC was 10000/cmm with differential count Neutrophil -42%, lymphocyte -52%, monocyte-03%, eosiphil-03%. Platelet count was 250000/cmm, peripheral blood film (PBF) showed non specific morphology.In Urine R/E Pus cell was found 2-3/HPF, Epithelial cell was 1-2/ HPF, The report of serum electrolytes was Na + 139mmo/l, K + -4.8 mmo/ l, Cl -100 mmo/l, Serum total CO 2 -22 mmol/L. Random blood sugar was 4.6mmol/L. S.bilirubin was 12umol/L. serum ALT -32U/L. Chest X-ray p/A view was normal. X-ray wrist joint showed appearance of 8 carpal bones which corresponds to 9 years of age. Dehydroepialdosterone (DHEA) level was raised (13.5 ng/dl). USG of whole abdomen showed a solid echogenic mass measuring about 8. 6x6.9cm in the right hypochondriac region in the upper pole of right kidney. It occupied the right adrenal area and lateral aspect of right lobe of liver. For resection of the tumour and getting specimen for histopathology the patient was referred to paediatric surgery unit.
After operation a mass of 8.6 x 6.9 cm was removed (Fig-3) . It seemed to arise from right adrenal gland extending up to nearby structures. It was categorized as stage III. Dehydroepiandrosterone (DHEA) measured after operation was within normal limit (1.05ng/dl). Histopathology (of adrenal mass): on gross examination-showed an irregular gray white piece of tissue (part of a mass) measuring 2.5x2x1.2 cm partly encapsulated, weight 10gm, surface was brownish and glandular. Microscopic examination showed a malignant tumour composed of adrenocortical cells. The tumour cells were arranged in nets and trabecular pattern. Many bizzare monstrous giant cells were seen. Areas of necrosis were also seen. These findings were consistent with adrenocortical carcinoma. After confirming the diagnosis the patient was discharged and advised to get admission in Paediatric Haemato-oncology department of Bangabandhu Sheikh Mujib Medical University for chemotherapy and further management.
Discussion:
Adrenal carcinoma usually presents with evidence of adrenal steroid hormone excess in approximately 60% of cases. Rapidly progressing Cushing's syndrome with or without virilization is the most frequent presentation. In patients from the German adrenocortical carcinoma (ACC) registry, autonomous cortisol secretion, either alone or in combination with other steroids, was detectable in 60% of the cases in which hormonal analysis had been performed prior to surgery 6 . However, not in all of these cases autonomous cortisol secretion was clinically suspected. Androgen secreting adrenocortical carcinomas (ACCs) in women induce hirsutism and virilization with deepening of the voice, male pattern baldness and oligoamenorrhea. Our patient presented with appearance of pubic hair, gradual enlargement of clitoris and gradual deepening of voice.
Estrogen-secreting adrenal tumours in males lead to gynecomastia and testicular atrophy and are almost invariably malignant 7 . High concentration of dehydroepiandrosterone sulfate (DHEA-S) is another clue suggesting adrenocortical carcinoma (ACC), whereas decreased serum DHEA-S concentrations are suggestive of a benign adenoma 7 Aldosteroneproducing adrenocortical carcinomas present with hypertension and pronounced hypokalemia (mean 8 However, severe hypokalemia is more likely to be caused by grossly elevated cortisol secretion, leading to insufficient renal cortisol inactivation by 11â-hydroxysteroid dehydrogenase type 2 with consecutive activation of the mineralocorticoid receptor. In many patients with a seemingly hormonally inactive adrenocortical carcinoma (ACC), high concentrations of steroid precursors like androstenedione or 17á-hydroxyprogesterone can often be demonstrated, thereby establishing the adrenocortical origin of the tumour. Hormonally inactive adrenocortical carcinomas (ACCs) usually present with abdominal discomfort (nausea, vomiting, abdominal fullness) or back pain caused by a mass effect of the large tumour. But our patient did not present with these complaints. So it appeared that the patient did not have a hormonally inactive tumour. In the Italian survey on adrenal incidentaloma, the occurrence of pain was significantly associated with adrenocortical carcinoma (ACC) and was not fully explained by large tumour size per se 9 However, an increasing percentage of adrenocortical carcinomas (ACCs) is discovered as incidentaloma during abdominal imaging 9 . Only occasionally patients present with fever, weight loss, and anorexia, and it is a remarkable feature of noncortisol-producing adrenocortical carcinoma (ACC) that well-being is often little affected by even a large tumour burden.
The molecular pathogenesis of adrenocortical carcinoma (ACC) has been the topic of recent reviews 10 but is still poorly understood. It is unclear whether adrenocortical carcinomas (ACCs) evolve from adrenal adenomas after a second hit paradigm. Although such a sequence has been observed in occasional cases 11 , long term follow-up data of incidentally discovered adrenal neoplasms suggest otherwise 12 Inactivating mutations at the 17p13 locus including the TP53 tumour suppressor gene and alterations of the 11p15 locus leading to IGF-II over expression are frequently observed. In vitro experiments suggest that overexpressed IGF-II acting via the IGF-I receptor is relevant for adrenal cancer cell proliferation 13 . Thus, the IGF-II IGF-I receptor pathway is a promising target for future therapies in adrenocortical carcinoma (ACC) 14 .
Until 2004, no official tumour nodes and metastasis (TNM) classification was available for adrenocortical carcinoma (ACC), and different staging systems were used 15, 16 , most often the Sullivan modification of the Macfarlane system. Accordingly, the new Union International Centre Cancer (UICC) staging system published by the World Health Organization (WHO) in 2004 is based on this classification 17 . Stages I and II describe localized tumours 5 cm or smaller and larger more than 5 cm, respectively. Locally invasive tumours or tumours with regional lymph node metastases are classified as stage III, whereas stage IV consists of tumors invading adjacent organs or presenting with distant metastases. However, the prognostic value of the different staging systems has never been compared directly in a large series of patients. Because one of the major objectives of staging classifications is to facilitate the exchange of information between treatment centers, we currently recommend the use of the new WHO system until evidence that a modification is needed becomes available. Whereas in older series 4,15 most patients were diagnosed with advanced disease (stage IV), recent studies have reported the highest percentage of patients in stage II 5, 18 , most likely reflecting improved and more widely available imaging technology.
Treatment of adrenocortical carcinoma begins with surgical care. Surgery is the mainstay of treatment and currently appears to be the major hope for cure. Every reasonable attempt should be made to render the patient disease-free at the primary sites of local invasion and at sites of metastatic disease. When metastatic disease cannot be removed or when biochemical evidence of tumours secretion persists after surgical removal, chemotherapy is often considered. Our patient presented with those problem which corresponded with other reports. According to the clinical presentation and laboratory findings this patient can be categorized as stage-Ill. After confirming diagnosis, total resection of adrenal mass was done. On follow up her condition was stable along with disappearance of secondary male characteristics.
